Jamie L Wagner
Overview
Explore the profile of Jamie L Wagner including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
103
Citations
704
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kandiah S, Altamimi S, Shaeer K, Holubar M, Wagner J
Antimicrob Steward Healthc Epidemiol
. 2025 Mar;
5(1):e68.
PMID: 40026754
The high cost of antimicrobials presents critical challenges for healthcare providers managing infections amidst the growing threat of antimicrobial resistance (AMR). High costs hinder access to necessary treatments, disproportionately affecting...
2.
Larson K, Powers B, Gatewood J, Amin A, Kilgore L, Wagner J, et al.
Surg Pract Sci
. 2025 Jan;
10():100081.
PMID: 39845601
Background: Our goal was to evaluate the clinical impact of local and systemic imaging in secondary breast angiosarcoma (SBAS) at diagnosis (DX) and in follow-up (FU). Materials And Methods: Singe-center...
3.
Cavaretta M, Wetterling J, Wagner J, Gallagher J
Curr Pharm Teach Learn
. 2024 Dec;
17(3):102273.
PMID: 39729759
Background: The integration of Electronic Health Records (EHRs) in healthcare has changed how healthcare is performed, necessitating a comprehensive understanding of these systems among pharmacists. The ability to navigate EHRs...
4.
Ogunsanya M, Wagner J, Bennett K, Medina M, Starnes S, Planas L
Am J Pharm Educ
. 2024 May;
88(7):100724.
PMID: 38821190
Objective: To evaluate the impact of a debate activity on pharmacy students' knowledge of public health and health policy topics. Methods: Forty-six second-year pharmacy students in a required public health...
5.
Wagner J, Jones B, Stover K, Cleary J, Bland C, Schipper K, et al.
Open Forum Infect Dis
. 2024 May;
11(5):ofae217.
PMID: 38737432
Daptomycin use for gram-positive infections has increased. This cost minimization analysis aimed to determine cost and/or time savings of daptomycin over vancomycin. The estimated hospital cost savings was US$166.41 per...
6.
Raheel A, Dalla S, Birney J, Aripoli A, Collins M, Larson K, et al.
Breast
. 2024 Feb;
74:103690.
PMID: 38368764
Background: Exposure to breast surgical oncology (BSO) and the multidisciplinary management of patients with breast cancer is limited in medical school. The purpose of this study was to assess changes...
7.
Stover K, Jordan T, Wagner J, Barber K
Drugs Context
. 2024 Jan;
13.
PMID: 38264401
Invasive fungal infections pose significant morbidity and mortality risks, particularly those caused by moulds. Available antifungal classes are limited by toxicities and are increasingly susceptible to resistance, particularly amongst challenging...
8.
Jackson C, Capino A, Stuart L, Wagner J
J Pediatr Pharmacol Ther
. 2023 Nov;
28(7):618-627.
PMID: 38025150
Objective: Limited data exist comparing indomethacin and ibuprofen for the treatment of patent ductus arteriosus (PDA). The objective was to compare the safety and efficacy of indomethacin and ibuprofen for...
9.
Chahine E, Clifford K, Ladikos N, Milito D, Morris L, Ranucci S, et al.
Sr Care Pharm
. 2023 Oct;
38(11):452-456.
PMID: 37885096
Senior care pharmacists are well-positioned to lead and drive antimicrobial stewardship (AMS) initiatives, not only through audit and data collection, but also through communication, collaboration, and cooperation with prescribers and...
10.
Collins C, Dumkow L, Kufel W, Nguyen C, Wagner J
Am J Health Syst Pharm
. 2023 Oct;
80(21):1577-1581.
PMID: 37879095
No abstract available.